Organogenesis Holdings
ORGO
40 hedge funds and large institutions have $12.5M invested in Organogenesis Holdings in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
29% more funds holding
Funds holding: 31 → 40 (+9)
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
6% more capital invested
Capital invested by funds: $11.8M → $12.5M (+$729K)
0.27% more ownership
Funds ownership: 1.74% → 2.01% (+0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGC
Angelo Gordon & Co
New York
|
+$825K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$418K |
| 3 |
BlackRock
New York
|
+$209K |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$155K |
| 5 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$153K |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$132K |
| 3 |
Millennium Management
New York
|
-$128K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$44.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$36.9K |
ORGO Hedge Fund Activity: Q3 2019 in Review
40 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2019, worth a combined $12.5M — up 6.2% from $11.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ORGO positions and 3 closed out — a net gain of 9 holders — while 10 added to existing stakes and 8 trimmed.
The largest buyer was Angelo Gordon & Co, opening a new position worth an estimated $825K. The largest seller was Charles Schwab, cutting an estimated $153K.
- 40 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2019, up from 31 in Q2 2019.
- Funds reported $12.5M of Organogenesis Holdings stock for Q3 2019, up 6.2% quarter-over-quarter.
- 12 funds opened new Organogenesis Holdings positions in Q3 2019 and 3 closed out, a net change of +9 holders.
- The largest Organogenesis Holdings buyer in Q3 2019 was Angelo Gordon & Co, an estimated $825K added.
- The largest Organogenesis Holdings seller in Q3 2019 was Charles Schwab, an estimated $153K sold.
Based on aggregated 13F filings for Q3 2019.